Insider Profile
Hutt, Karen
1
Companies Filed At
1
Open-Market Buys (2yr)
$1.3M
Buy Value (2yr, open-market)
Feb 25, 2026
Most Recent Trade
62
Credibility
Score
82%
Hit Rate
+6.3%
Avg 90d Return
+9.8%
Median 90d Return
28
Evaluated Trades
+14.4%
Best Trade
-11.5%
Worst Trade
Hit rate and returns are based on 28 open-market buys with evaluable 90-day outcomes. Score reflects historical conviction, not a guarantee of future performance. This insider has a solid track record of profitable timing.
Cross-Company Track Record
THIN HISTORY
100%
Hit Rate · 90d
-4.0%
Median Alpha · 90d
1
Closed Buys Evaluated
0%
Beat XIU
All-insider base rate: 59% hit rate  · +1.3% mean alpha (n=11504)
size concentrated
Entry: closing price on SEDI filing date (point-in-time). Exit: 90 calendar days later. Alpha vs XIU.TO (iShares TSX 60). Closed trades only. Not investment advice.
Research 1 closed buys with individual return outcomes available on the Research plan.
Date Company Role Nature Dir. Shares Price Value Score
Feb 25, 2026 $EMA
Emera
Comp. Grant Buy 9,549 $67.02 $640K 86
Feb 25, 2026 $EMA
Emera
Plan / DRIP Buy 5,466 $67.02 $366K 86
Feb 25, 2026 $EMA
Emera
Comp. Grant Buy 42,400 $69.85 $3.0M 86
Feb 25, 2026 $EMA
Emera
Comp. Grant Buy 4,780 $67.02 $320K 86
Feb 25, 2026 $EMA
Emera
Plan / DRIP Buy 10,917 $67.02 $732K 86
Feb 25, 2026 $EMA
Emera
Comp. Grant Buy 4,157 $67.02 $279K 86
Dec 31, 2025 $EMA
Emera
Plan / DRIP Buy 1,596 86
Dec 31, 2025 $EMA
Emera
Plan / DRIP Buy 799 86
Dec 31, 2025 $EMA
Emera
Plan / DRIP Buy 1,254 86
Dec 31, 2025 $EMA
Emera
Plan / DRIP Buy 192 $60.68 $12K 86
Sep 26, 2025 $EMA
Emera
Exercise Buy 20,400 $46.19 $942K 86
Sep 26, 2025 $EMA
Emera
Exercise Sell 20,400 $46.19 $942K 86
Sep 26, 2025 $EMA
Emera
Open Market Buy 20,400 $65.83 $1.3M 86
Feb 25, 2025 $EMA
Emera
Comp. Grant Buy 50,400 $52.88 $2.7M 86
Feb 20, 2025 $EMA
Emera
Other Sell 8,987 $52.88 $475K 86
Feb 20, 2025 $EMA
Emera
Comp. Grant Buy 5,441 $52.88 $288K 86
Feb 20, 2025 $EMA
Emera
Comp. Grant Buy 10,874 $52.88 $575K 86
Feb 20, 2025 $EMA
Emera
Other Sell 4,497 $52.88 $238K 86
Feb 20, 2025 $EMA
Emera
Comp. Grant Buy 4,456 $52.88 $236K 86
Dec 31, 2024 $EMA
Emera
Plan / DRIP Buy 1,244 $50.30 $63K 86
Dec 31, 2024 $EMA
Emera
Plan / DRIP Buy 900 $50.30 $45K 86
Dec 31, 2024 $EMA
Emera
Plan / DRIP Buy 1,799 $50.30 $90K 86
Dec 31, 2024 $EMA
Emera
Plan / DRIP Buy 255 $48.84 $12K 86
Feb 28, 2023 $EMA
Emera
Other Sell 5,124 $51.66 $265K 86
Feb 28, 2023 $EMA
Emera
Other Sell 2,558 $51.66 $132K 86
Feb 27, 2023 $EMA
Emera
Comp. Grant Buy 9,321 $51.66 $482K 86
Feb 27, 2023 $EMA
Emera
Comp. Grant Buy 34,100 $54.64 $1.9M 86
Feb 27, 2023 $EMA
Emera
Comp. Grant Buy 4,667 $51.66 $241K 86
Dec 31, 2022 $EMA
Emera
Plan / DRIP Buy 182 $59.53 $11K 86
Feb 23, 2022 $EMA
Emera
Other Sell 7,218 $59.77 $431K 86
Feb 23, 2022 $EMA
Emera
Comp. Grant Buy 3,154 $59.77 $189K 86
Feb 16, 2022 $EMA
Emera
Comp. Grant Buy 7,679 $59.77 $459K 86
Feb 16, 2022 $EMA
Emera
Comp. Grant Buy 33,100 $58.26 $1.9M 86
Feb 16, 2022 $EMA
Emera
Comp. Grant Buy 3,842 $59.77 $230K 86
Dec 31, 2021 $EMA
Emera
Plan / DRIP Buy 158 $56.32 $9K 86
Feb 24, 2021 $EMA
Emera
Comp. Grant Buy 3,312 86
Feb 24, 2021 $EMA
Emera
Other Sell 5,336 86
Feb 18, 2021 $EMA
Emera
Comp. Grant Buy 36,000 $51.12 $1.8M 86
Feb 18, 2021 $EMA
Emera
Comp. Grant Buy 3,367 $54.66 $184K 86
Feb 18, 2021 $EMA
Emera
Comp. Grant Buy 6,733 $54.66 $368K 86
Dec 31, 2020 $EMA
Emera
Plan / DRIP Buy 162 $52.85 $9K 86
Feb 26, 2020 $EMA
Emera
Comp. Grant Buy 2,960 $54.62 $162K 86
Feb 26, 2020 $EMA
Emera
Other Sell 4,134 $54.62 $226K 86
Feb 20, 2020 $EMA
Emera
Comp. Grant Buy 2,233 $54.62 $122K 86
Feb 20, 2020 $EMA
Emera
Comp. Grant Buy 4,474 $54.62 $244K 86
Feb 20, 2020 $EMA
Emera
Comp. Grant Buy 20,400 $60.03 $1.2M 86
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.